Trading status Status de
  • Prices realtime
    • Indizes
      • Germany 40
      • MID Germany 50
      • TEC Germany 30
      • USA 30
      • EUROPE 50
      • TEC USA 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • Newsletter
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 16990
  • 16991
  • 16992
  • …
  • ›
  • »

2024-09-25

Seelos Therapeutics to execute 1-for-16 reverse stock split

2024-09-25

Altima Resources acquires assets in Alberta, Canada

2024-09-25

Jaguar Health, Inc.: Jaguar Health to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024

2024-09-25

Altima Resources Ltd.: Altima Announces Strategic Asset Acquisition in Alberta, Canada

2024-09-25

PTX Metals′ Green Canada Subsidiary Announces Acquisition of Thelon Basin Uranium Claims

2024-09-25

Enveric Biosciences Presents Data on Lead Product Candidate, EB-003, at 7th Neuropsychiatric Drug Summit

2024-09-25

UK′s Largest Greenhouse Complex, Thanet Earth, Adopts Intelligent Bio Solutions′ Fingerprint Drug Test to Enhance Workplace Safety

2024-09-25

Gulf Navigation Board Approves Acquisition Of Companies And Assets Owned By Brooge Energy

2024-09-25

Koryx Copper Announces $10 Million Non-Brokered Private Placement

2024-09-25

EQS-News: Lübke Kelber AG: Neubauwerte trading in future as Lübke Kelber Living

2024-09-25

Palisade Bio Provides Update on Progress Toward Launch of Phase 1 Human Clinical Study for Lead Program, PALI-2108 for the Treatment of Ulcerative Colitis

2024-09-25

Cidara Therapeutics Announces Two Presentations on Innovative Drug-Fc Conjugate, CD388, at the 2024 OPTIONS XII for the Control of Influenza Conference

  • «
  • ‹
  • …
  • 16990
  • 16991
  • 16992
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Realtimeprices 16/Sep/2026 16:19:18
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies